Citations

Clear

3057 citation(s) found for "Cd, Johnson".

Comparison of Time to Next Treatment or Death Between Front‐Line Daratumumab, Lenalidomide, and Dexamethasone ( DRd ) Versus Bortezomib, Lenalidomide, and Dexamethasone ( VRd
Gautam, Santosh , Lafeuille, Marie‐Hélène, Rossi, Carmine , Moore, Bronwyn, Tardif‐Samson, Anabelle , Thompson‐Leduc, Philippe , Fu, Alex Z. , Cortoos, Annelore, Kaila, Shuchita, Rossi, Carmine , Hansen, Doris K. , Fonseca, Rafaël

Mayo Clinic

Cancer Medicine | November 1, 2024 | Volume: 13 | Issue: 21 | Pages: No page available

10.1002/cam4.70308 | PMID 39486091 Get It

ABSTRACT Introduction Daratumumab, lenalidomide, and dexamethasone (DRd) and bortezomib, lenalidomide, and dexamethasone (VRd) are the only preferred treatment regimens for patients with transplant‐ineligible (TIE) newly diagnosed multiple myeloma (NDMM). As there are no randomized head‐to‐head studies of DRd versus VRd, this analysis aimed to compare real‐world time‐to‐next‐treatment (TTNT) or death in this population. Methods Patients with NDMM who received front‐line (FL) DRd or VRd were identified from the Acentrus database (January 1, 2018 to May 31, 2023). Those with a record of a stem cell transplant or aged < 65 years were excluded to limit analysis to the TIE population. Inverse probability of treatment weighting was used to balance baseline patient characteristics. A doubly robust Cox proportional hazards model was used to compare TTNT or death between cohorts. Results A total of 149 and 494 patients who initiated DRd and VRd, respectively, were identified. After weighting (weighted N DRd = 302, weighted N VRd = 341), cohorts had similar baseline characteristics. Of these, 98 (32.4%) DRd and 175 (51.2%) VRd patients either received a subsequent line of therapy or died, with a median TTNT or death of 37.8 months in the DRd cohort and 18.7 months in the VRd cohort (hazard ratio: 0.58, 95% confidence interval: 0.35, 0.81; p < 0.001). Conclusion Treatment of TIE NDMM patients with DRd led to a significantly longer TTNT or death compared to VRd, evidenced by a 42% risk reduction, supporting the effectiveness of DRd over VRd as FL treatment in this patient population.
A pilot trial of integrating the Patient-Reported Outcome Measurement Information System (PROMIS®) into rheumatology care
Gedert, Rosemary J. , Ochocki, Danielle N., Kortam, Neda , Huang, Suiyuan, Chakrabarti, Katherine , Ford, Julia A. , Garber, Martin E. , Ognenovski, V., Cella, David , Nagaraja, Vivek , Lee, Jiha , Roofeh, David , Khanna, Dinesh

Mayo Clinic

Clinical and Experimental Rheumatology | October 31, 2024 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.55563/clinexprheumatol/fp914f | PMID 39480493 Get It

S1288 Real-World Effectiveness of Ozanimod for Ulcerative Colitis in Patients With Prior Advanced Therapy Exposure: A Multicenter Study
Scalzo, Nicholas , Lieto, Stephen, Huang, Katherine , Xu, Anthony , Rajauria, Palak , Ayoub, Malek , Johnson, Amanda M. , Yarur, Andrés , Dulaney, David , Seth, Nikhil , Shukla, Richa, Sokol, Uyen, Sands, Bruce E., Yarur, Andres J , Khan, Abdul Wali , Pekow, Joel , Patel, Anish A , Bishu, Shrinivas , Shukla, Richa, Jain, Anjali , Rubin, David T. , Sands, Bruce E , Deepak, Parakkal , Ungaro, Ryan C.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S921-S921

10.14309/01.ajg.0001034520.61834.16 Get It

S758 Resilience in Patients With Functional Dyspepsia: A Prospective Questionnaire Study
Chase, Robert C., Cangemi, David J. , Keefer, Laurie , Chase, Katherine Johnson, Lacy, Brian E. , Chase, Robert C., Lacy, Brian E.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S520-S520

10.14309/01.ajg.0001032400.92789.6d Get It

S456 Impact of Preference-Based Digital Navigation on Multi-Target Stool DNA Test Adherence in a Large Colorectal Cancer Screening Population
Greene, Mallik , Pew, Timo, Johnson, Will K., Ozbay, A. Burak , Kisiel, John B. , Fendrick, A. Mark , Johnson, Will K., Limburg, Paul J.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S321-S321

10.14309/01.ajg.0001031192.87627.ec Get It

S426 Gap Closure Adherence to Multi-Targeted Stool DNA Test for Colorectal Cancer Screening in an Insured Cohort
Le, Quang A. , Greene, Mallik , Pew, Timo, Philp, Alisdair R. , Doré, Michaël , Johnson, Will K., Ozbay, A. Burak , Fendrick, A. Mark , Ebner, Derek W. , Kisiel, John B. , Limburg, Paul J.

Mayo Clinic

American Journal of Gastroenterology | October 24, 2024 | Volume: 119 | Issue: 10S | Pages: S302-S302

10.14309/01.ajg.0001031072.99009.1f Get It

Recommendations for permanent sleep telehealth: an American Academy of Sleep Medicine position statement
Vohra, Kunwar Praveen, Johnson, Karin G. , Dalal, A, Ibrahim, Sally , Krishnan, Vidya , Abbasi-Feinberg, Fariha, Abreu, Alexandre Rocha, Bandyopadhyay, Anuja , Gurubhagavatula, Indira , Kuhlmann, David, Olson, Eric J. , Shelgikar, Anita V., Trotti, Lynn Marie , Rowley, James A. , Trotti, Lynn Marie , Martin, Jennifer L. , Patil, Susheel P. , Wickwire, Emerson M. , Kapur, Vishesh K.

Mayo Clinic

Journal of Clinical Sleep Medicine | October 23, 2024 | Volume: 21 | Issue: 2 | Pages: 401-404

10.5664/jcsm.11438 | PMID 39441539 Get It

Development of a Uniform Apheresis Case Report Form for Standardized Collection of Apheresis Data
Johnson, Andrew D., Szczepiorkowski, Zbigniew M. , Karam, Oliver , Nellis, Marianne E. , Schwartz, Joseph, Wu, Yanyun , Armendariz, Tomas , Burgstaler, Edwin A. , Collins, Laura , Geile, Kira, Pavenski, Katerina , Sanchez, Amber P. , Witt, Volker, Muthusamy, Amutha, Ramesh, Vidhyalakshmi , Thao, Mai See , Chlebeck, Therese M., Zantek, Nicole D. , Karam, Oliver , Armendariz, Tomas , Burgstaler, Edwin, Zantek, Nicole D , Balogun, Rasheed A. , Schneiderman, Jennifer , Winters, Jeffrey L. , Pavenski, Katerina , Pederson, Thomas

Mayo Clinic

Journal of Clinical Apheresis | October 18, 2024 | Volume: 39 | Issue: 5 | Pages: No page available

10.1002/jca.22146 | PMID 39420527 Get It

ABSTRACTApheresis is performed worldwide for an increasing number of indications. The development of common data elements (CDE) for apheresis related areas may facilitate conduct of new research, enhance quality initiatives including benchmarking, and improve patient care. This report describes the systematic development of the Uniform Apheresis Case Report Form (UACRF) as part of the Apheresis in the United States (ApheresUS) program. A consensus panel of 17 diverse experts in apheresis, related specialties, and electronic case report form (eCRF), and database development was assembled. The panel met via online conferencing from November 17, 2020 to December 1, 2021. A draft document was posted online for public comment from October 11, 2021 to November 10, 2021. Feedback was collected using an online survey tool. The consensus panel revised the UACRF. This version was converted to an eCRF with additional changes made to improve usability in this format. The final version of the UACRF was created on August 24, 2023. The UACRF contains 16 modules: procedure and subject eligibility, patient demographics, general procedure information, laboratory parameters, vascular access, common procedure elements, eight procedure specific modules (mononuclear cell collection and seven therapeutic modalities), outcomes, and site information. A total of 137 data elements were created, including 57 with one or more subelements. The UACRF is the first systematic attempt to develop CDE for therapeutic apheresis and white blood cell collections. Further validation of the UACRF is necessary to confirm the tool's ability to collect the relevant data elements and determine the usability of the form.
Feasibility of thin-slice, low noise images created using multi-kernel synthesis to replace multiple image series in head CT
Diehn, Felix E. , Nagelschneider, Alex A. , Passe, Theodore J. , Nelson, Brandon , Cardona, Daniel Gomez , Huber, Nathan R. , Missert, Andrew D, Yu, Lifeng , Johnson, Matthew P. , Holmes, David R. , Lee, Yong S. , Thorne, Jamison E. , Diehn, Felix E , DeLone, David R. , Nelson, Brandon J, Gomez Cardona, Daniel G , Thorne, Jamison E , Fletcher, Joel G , Inoue, Akitoshi , Missert, Andrew D, Yu, Lifeng , McCollough, Cynthia H. , Fletcher, Joel G.

Mayo Clinic

Acta Radiologica | October 17, 2024 | Volume: 65 | Issue: 11 | Pages: 1411-1421

10.1177/02841851241280365 | PMID 39415759 Get It

Background SynthesiZed Improved Resolution and Concurrent nOise reductioN (ZIRCON) is a multi-kernel synthesis method that creates a single series of thin-slice computed tomography (CT) images displaying low noise and high spatial resolution, increasing reader efficiency and minimizing partial volume averaging. Purpose To compare the diagnostic performance of a single set of ZIRCON images to two routine clinical image series using conventional CT head and bone reconstruction kernels for diagnosing intracranial findings and fractures in patients with trauma or suspected acute neurologic deficit. Material and Methods In total, 50 patients underwent clinically indicated head CT in the ER (15 normal, 35 abnormal cases). A non-reader neuroradiologist established the reference standard. Three neuroradiologists reviewed two routine clinical series (head and bone kernels) and a single ZIRCON series, detecting intracranial findings or fractures and rating confidence (0–100). Sensitivity, specificity, and jackknife free-response receiver operating characteristic (JAFROC) figure of merit (FOM) were compared (limit of non-inferiority: −0.10). Results ZIRCON and conventional images demonstrated comparable performance for fractures (sensitivity: 51.5% vs. 54.5%; specificity: 40.2% vs. 34.2%) and intracranial findings (sensitivity: 88.2% vs. 91.4%; specificity: 77.2% vs. 73.7%).The estimated difference of JAFROC FOM demonstrated ZIRCON non-inferiority for acute pathologies overall (0.003 [95% CI=−0.051–0.057]) and fractures (0.048 [95% CI=−0.050–0.145]) but not for intracranial findings alone (−0.024 [95% CI=−0.100–0.052]). Conclusion Thin-slice, low noise, and high spatial resolution images can be created to display intracranial findings and fractures replacing multiple images series in head CT with similar performance. Future studies in more patients and further algorithmic development are warranted.
Penile and Scrotal Porokeratosis: A Single-Institution Experience
Gupta, Sounak , Lehman, Julia S. , Wieland, Carilyn N. , Johnson, Emma F. , Johnson, E F , Lehman, Julia S , Tekin, Burak , Guo, Ruifeng

Mayo Clinic

The American Journal of Dermatopathology | October 16, 2024 | Volume: 46 | Issue: 11 | Pages: 721-728

10.1097/dad.0000000000002801 | PMID 39413268 Get It

Abstract: There is a paucity of data regarding porokeratosis confined to the penis and scrotum. We evaluated our single-institutional experience regarding this entity. We interrogated our pathology archive for all specimens from the penis or scrotum, signed out as porokeratosis between 2000 and 2022. Clinical and histopathological features were reviewed, including the number of cornoid lamella(e) per tissue profile and squamous dysplasia. Nine patients were included in the study. The median age at the time of diagnosis was 51 years. Multiple lesions were present in 3 patients. Six patients had exclusively penile involvement, whereas 2 patients had exclusively scrotal involvement. One patient had multiple lesions consistent with porokeratosis ptychotropica, extending from the scrotum to the buttocks and perineum. Clinically, a collarette of scale was noted in 3 patients and diagnosis of porokeratosis was considered in 1 patient before biopsy. Histopathologically, 2 patients exhibited multiple cornoid lamellae in the same profile and 1 patient had follicular cornoid lamellae. Focal squamous dysplasia was only present in 1 patient. Follow-up was available for 5 patients (median duration: 35 months). In 4 patients, the lesions were removed completely during the shave biopsy procedure. At the past follow-up, there were no signs of recurrence or malignant transformation to squamous cell carcinoma in any patient. Porokeratosis involving the penis and/or scrotum may be elusive to diagnosis based on clinical features alone, emphasizing the role of histopathological examination. Increased awareness of this entity may help better delineate its clinicopathological presentation and appropriate classification.